NEW YORK (GenomeWeb News) — Celera today said it has closed its $33 million acquisition of Atria Genetics, a maker of human leukocyte antigen-testing products used in organ donor matching.
Celera said it plans to integrate all of Atria’s 13 employees into its company.
Celera also said it expects the acquisition will be accretive to its earnings by the second half of 2008.
The company disclosed its plans to buy the South San Francisco, Calif.-based company last month.